Wells Fargo
NMTC icon

Wells Fargo’s NeuroOne Medical Technologies NMTC Stock Holding History

Wells Fargo’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$505 Sell
166
-1
-0.6% -$4 ﹤0.01% 6515
2026
Q1 		$777 Hold
167
– – ﹤0.01% 6362
2025
Q4 		$758 Sell
167
-55
-25% -$250 ﹤0.01% 6306
2025
Q3 		$1.19K Hold
222
– – ﹤0.01% 6243
2025
Q2 		$904 Hold
222
– – ﹤0.01% 6318
2025
Q1 		$1.13K Buy
222
+166
+296% +$1.05K ﹤0.01% 6225
2024
Q4 		$275 Hold
56
– – ﹤0.01% 6344
2024
Q3 		$330 Buy
+56
New +$280 ﹤0.01% 6197
2024
Q2 		– Sell
-32
Closed -$232 – 7277
2024
Q1 		$232 Buy
32
+3
+10% +$23 ﹤0.01% 6459
2023
Q4 		$277 Buy
29
+1
+4% +$7 ﹤0.01% 6519
2023
Q3 		$148 Buy
28
+8
+40% +$54 ﹤0.01% 6657
2023
Q2 		$143 Buy
20
+2
+11% +$16 ﹤0.01% 6791
2023
Q1 		$171 Buy
18
+1
+6% +$9 ﹤0.01% 6818
2022
Q4 		$125 Hold
17
– – ﹤0.01% 6746
2022
Q3 		$0 Buy
17
+2
+13% +$19 ﹤0.01% 7133
2022
Q2 		$0 Buy
15
+2
+15% +$11 ﹤0.01% 7262
2022
Q1 		$0 Hold
13
– – ﹤0.01% 7568
2021
Q4 		$0 Buy
13
+4
+44% +$65 ﹤0.01% 7618
2021
Q3 		$0 Buy
+9
New +$258 ﹤0.01% 7333

Other funds holding NMTC

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Wells Fargo's NMTC Position: Q2 2026 in Review

Wells Fargo reduced its NeuroOne Medical Technologies (NMTC) stake by 0.6% in Q2 2026, selling an estimated $4 and leaving 166 shares worth $505. The position accounts for ﹤0.01% of the portfolio, ranked #6515.

Wells Fargo first reported a position in NMTC in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.19K in Q3 2025. 26 funds tracked by Wall St. Rank hold NMTC as of Q2 2026.

  • Wells Fargo held 166 shares of NeuroOne Medical Technologies worth $505 as of Q2 2026.
  • Wells Fargo sold 1 NeuroOne Medical Technologies share in Q2 2026, an estimated $4.
  • NeuroOne Medical Technologies made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6515 holding.
  • Wells Fargo first reported a position in NeuroOne Medical Technologies in Q3 2021 and has held it in 19 quarters since.
  • Wells Fargo's NeuroOne Medical Technologies position peaked at $1.19K in Q3 2025.
  • 26 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.